Journals / Bakırköy Tıp Dergisi / 2015 / Cilt: 11 - Sayı: 4

Skin hemorrhage due to uncontrolled warfarin therapy: case report

Kontrolsüz Warfarin Kullanımına Bağlı Ciltte Kanama: Olgu sunumu

Pages
170–172
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, a case, who developed skin bleeding caused by receiving warfarin as prophylaxis because of atrial fibrillation and aortic valve replacement (AVR), was presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anticoagulant therapy is a vital method of treatment and prophylaxis of thromboembolic diseases which clinically have a wide spectrum.
📊
Key Findings & Data:It is advised that the reversal of anticoagulation should be done with the treatment of vitamin K, prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) as soon as possible.
💡
Conclusion & Impact:In this article, a case, who developed skin bleeding caused by receiving warfarin as prophylaxis because of atrial fibrillation and aortic valve replacement (AVR), was presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Anticoagulant therapy is a vital method of treatment and prophylaxis of thromboembolic diseases which clinically have a wide spectrum. Sometimes the most important complication of anticoagulant therapy is bleeding that may threaten life. Therefore, it is vital that anticoagulant therapy be planned so that it does not lead to thrombosis or bleeding and clinical and laboratory follow-up should be performed carefully. Skin bleeding caused by oral anticoagulants rarely occurs. It is advised that the reversal of anticoagulation should be done with the treatment of vitamin K, prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) as soon as possible. In this article, a case, who developed skin bleeding caused by receiving warfarin as prophylaxis because of atrial fibrillation and aortic valve replacement (AVR), was presented.

Özet

Antikoagülan tedavi, klinik tablo açıdan geniş bir spektrum oluşturan tromboembolik hastalıkların profilaksi ve tedavisinde yaşamsal önem taşıyan bir tedavi yöntemidir. Antikoagülan tedavinin bazen hasta hayatını tehdit edebilen en önemli komplikasyonu kanamadır. Bu nedenle antikoagülan tedavinin tromboz veya kanamaya yol açmayacak şekilde planlanması, klinik ve laboratuvar takibinin titizlikle yapılması yaşamsal önem taşımaktadır. Oral antikoagülanlara bağlı cilt kanamaları çok nadir görülmektedir. Tedavide K vitamini, protrombin kompleks konsantresi (PCC) ve taze donmuş plazma (TDP) ile antikoagülasyonun bir an önce tersine çevrilmesi önerilmektedir. Bu makalede, atrial fibrilasyon ve aort valv replasmanı (AVR) nedeniyle profilaktik olarak warfarin alımına bağlı ciltte kanama gelişen bir olgu sunulmuştur.

🔖

Cite This Article

KARA, H., BAYIR, A., AK, A., DEĞİRMENCİ, S., SERİN, H. (2015). Skin hemorrhage due to uncontrolled warfarin therapy: case report. Bakırköy Tıp Dergisi, Cilt: 11 - Sayı: 4, 170–172. https://ajindex.com/articles/128882

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Lee NJ, Peckitt NS. Treatment of a sublingual hematoma with medicinal leeches: report of case. J Oral Maxillofac Surg 1996; 54: 101-103
  2. Feldstein AC, Smith DH, Perrin N, et al. Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med. 2006; 166: 1009-1015
  3. Hambleton J. Drugs used in disorders of coagulation. In: Katzung BG (ed). Basic and clinical pharmacology. New york; McGraw-Hill 2004: p. 543-560
  4. Visser LE, Bleumink GS, Trienekens PH, et al. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Br J Haematol 2004; 127: 85-89
  5. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 1993; 95: 315-328
  6. Sternberg MC, Pettyjohn FS. Warfarin sodium-induced skin necrosis. Ann Emerg Med 1995; 26: 94-97
  7. Baker H, Levene GM. Cutaneous reactions to anticoagulants. Br J Dermatol 1969; 81: 236-238
  8. Kucher N, Castellanos LR, Quiroz R, et al. Time trends in warfarin- associated hemorrhage. Am J Cardiol 2004; 94: 403-406
  9. Wiedermann CJ, Stockner I. Warfarin-induced bleeding complications - clinical presentation and therapeutic options. Thromb Res 2008; 122: 13-18
  10. Weber JE, Charles MJ, Pollack V. Anticoagulants, antiplatelet agents and fibrinolytics. In: Tintinalli JE, Kelen GD, Stapczynski JS (Eds). Emergency medicine: a comprehensive study guide. 6th ed. New York; McGraw-Hill 2004: p. 1354-1363.